CasZ Ribonucleoprotein Complex Enhances Genome Editing Specificity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current CRISPR-Cas systems face challenges in efficiently targeting and modifying specific sequences in nucleic acids, particularly in achieving high fidelity and specificity in DNA detection and editing.
Innovation Solution
The development of CasZ proteins, guide RNAs, and transactivating noncoding RNAs (trancRNAs) that form ribonucleoprotein complexes with specific sequence targeting capabilities, enabling precise binding and modification of target nucleic acids.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional CRISPR-Cas systems are used for DNA targeting and modification, then genome editing capability is provided, but specificity and fidelity in target sequence recognition are insufficient
Solution Approach 1:
The CRISPR-Cas system is divided into distinct functional components: the CasZ protein for catalytic activity, guide RNAs for sequence recognition, and trancRNAs for transcriptional activation. This segmentation allows each component to be optimized independently for its specific function, thereby improving overall specificity and fidelity.
Solution Approach 2:
Guide RNAs serve as intermediary molecules that bridge the CasZ protein and the target DNA sequence. The guide RNA transcribes the spacer sequence and forms a ribonucleoprotein complex with CasZ, enabling precise target recognition and positioning before catalytic action occurs.
2Productivity
If CRISPR-Cas systems are used for genome manipulation, then editing capability is achieved, but efficiency in targeting specific sequences is limited
Solution Approach 1:
The CasZ protein is designed to perform multiple functions within a single complex: it provides catalytic activity, binds to guide RNAs, and facilitates target DNA recognition and cleavage. This multi-functionality increases the efficiency of the system while maintaining high specificity through the guide RNA component.
Solution Approach 2:
The system utilizes changes in molecular parameters such as the formation of ribonucleoprotein complexes and transcriptional activation by trancRNAs to enhance targeting efficiency. The trancRNA binds to the CRISPR array and promotes transcription of guide RNAs, thereby increasing the concentration of active targeting complexes.
3Manufacturing precision
If existing CRISPR-Cas components are used, then basic genome editing function is provided, but precision in regulation and detection is inadequate
Solution Approach 1:
The guide RNA is nested within the ribonucleoprotein complex formed with the CasZ protein, and the trancRNA is nested within the CRISPR array structure. This nested arrangement allows compact integration of multiple functional elements while maintaining precise control over each component's activity.
Solution Approach 2:
The trancRNA autonomously binds to the CRISPR array and initiates transcription of guide RNAs without requiring external factors. This self-service mechanism simplifies the regulation system while maintaining precision, as the system automatically generates the necessary guide RNAs for targeted editing.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These compositions and methods achieve high specificity and efficiency in targeting and modifying nucleic acids, enhancing the precision and effectiveness of genome editing and regulation.
Implementation Method 1
a guide RNA that binds to and provides sequence specificity to the CasZ protein
Implementation Method 2
CRISPR-Cas systems consist of Cas proteins, which are involved in acquisition, targeting and cleavage of foreign DNA or RNA
Implementation Method 3
a CasZ transactivating noncoding RNA (trancRNA) that binds to the CRISPR array and promotes transcription of guide RNAs
Data Source
AI summary
Provided are compositions and methods that include one or more of: (1) a “CasZ” protein (also referred to as a CasZ polypeptide), a nucleic acid encoding the CasZ protein, and/or a modified host cell comprising the CasZ protein (and/or a nucleic acid encoding the same); (2) a CasZ guide RNA that binds to and provides sequence specificity to the CasZ protein, a nucleic acid encoding the CasZ guide RNA, and/or a modified host cell comprising the CasZ guide RNA (and/or a nucleic acid encoding the same); and (3) a CasZ transactivating noncoding RNA (trancRNA) (referred to herein as a “CasZ trancRNA”), a nucleic acid encoding the CasZ trancRNA, and/or a modified host cell comprising the CasZ trancRNA (and/or a nucleic acid encoding the same).